Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study-Reference-Cited by-同舟云学术

Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study

Published:2009-12-25 Issue:1 Volume:120 Page:127-134
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Briot Karine,Tubiana-Hulin Michèle,Bastit Laurent,Kloos Ioana,Roux Christian

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-009-0692-7.pdf

Reference24 articles.

1. Winer EP, Hudis C, Burstein HJ et al (2005) American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor positive breast cancer: status report 2004. J Clin Oncol 23:619–629

2. Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60–62

3. Coombes RC, Kilburn LS, Snowdon CF et al (2007) Survival and safety of exemestane versus tamoxifen after 2–3 years’ tamoxifen treatment (Intergroup Exemestane Study): a randomized controlled trial. Lancet 369:559–570

4. Coates AS, Keshaviah A, Thürlimann B et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25:486–492

5. Poole R, Paridaens R (2007) The use of third generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review. Curr Opin Oncol 19:564–572

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of exercise in aromatase inhibitor‐induced arthralgia;PM&R;2024-05-23

2. Breast cancer survivorship;Journal of Surgical Oncology;2024-03-27

3. Mise à jour du diagnostic différentiel et du traitement des douleurs articulaires de la ménopause;Rheuma Plus / Schweiz;2024-03

4. Current and future advances in practice: aromatase inhibitor–induced arthralgia;Rheumatology Advances in Practice;2024-01-01

5. Risk Identification and Treatment of Hormone Therapy Related Adverse Events in Patients of Carcinoma Breast;Complications of Cancer Therapy: Best Practices in Prevention and Management;2024